Article Details

B7-H3/CD276: novel immune checkpoint and jack of all trades | ITT - Dove Medical Press

Retrieved on: 2025-09-04 16:13:55

Tags for this article:

Click the tags to see associated articles and topics

B7-H3/CD276: novel immune checkpoint and jack of all trades | ITT - Dove Medical Press. View article details on hiswai:

Excerpt

Monoclonal antibodies aim to block B7-H3/CD276-mediated immune evasion or elicit antibody-dependent cellular cytotoxicity. Enoblituzumab is a ...

Article found on: www.dovepress.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo